Dissociation between tuberculin skin test and in vitro IFN-γ responses following neonatal BCG vaccination

Journal of Tropical Pediatrics

Volumn 52, Issue 2, 2006, Pages 136-140

  Ota, Martin O C ^a,b   Goetghebuer, Tessa ^a   Vekemans, Johan ^a   Okoko, Brown J ^a   Newport, Melanie J ^a   McAdam, Keith P W J ^a   Marchant, Arnaud ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 5; TUBERCULIN;

ARTICLE; BCG VACCINATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFANCY; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PASSIVE IMMUNIZATION; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; TUBERCULOSIS;

AGING; BCG VACCINE; HUMANS; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKINS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33645856770     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmi087     Document Type: Article

References (21)

1. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101: 2364-9.
2. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-54.
3. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-9.
4. Waksman BH. Delayed (cellular) hypersensitivity. In: Samter M. (ed.) Immunological Diseases. 2nd edn. Little Brown, Boston. 1971. pp. 220-52.
5. Shaaban MA, Abdul Ati M, Bahr GM, Standford JL, Lockwood DN, McManus IC. Revaccination with BCG: Its effects on skin tests in Kuwaiti senior school children. Eur Respir J 1990; 3: 187-91.
6. Bahr GM, Stanford JL, Rook GA, Rees RJ, Abdelnoor AM, Frayha GJ. Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon. Tubercle 1986; 67: 205-18.
7. al-Kassimi FA, al-Hajjaj MS, al-Orainey IO, Bamgboye EA. Does the protective effect of neonatal BCG correlate th vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995; 152: 1575-8.
8. Fine PE, Sterne JA, Ponnighaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344: 1245-9.
9. Weir RE, Fine PE, Nazareth B, Floyd S, Black GF, King E, et al. Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol 2003; 134: 285-94.
10. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: Two randomised controlled studies. Lancet 2002; 359: 1393-401.
11. Fjallbrant H, Ridell M, Larsson LO. The tuberculin skin test in reaction to immunological in vitro reactions in BCG-vaceinated healthcare workers. Eur Respir J 2001; 18: 376-80.
12. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999; 163: 2249-55.
13. Vekemans J, Amedei A, Ota MO, D'Elios MM, Goetghebuer T, Ismaili J, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 2001; 31: 1531-5.
14. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168: 919-25.
15. Reichman L. Tuberculin skin testing. Chest 1979; 76(Suppl): 764-70.
16. O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/ Gambia Government/University College London Medical School working group on mother-child transmission of HIV. Aids 2000; 14: 441-8.
17. Grindulis H, Baynham MI, Scott PH, Thompson RA, Wharton BA. Tuberculin response two years after BCG vaccination at birth. Arch Dis Child 1984; 59: 614-9.
18. Karalliedde S, Katugaha LP, Uragoda CG. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987; 68: 33-8.
19. Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965; 36: 624-7.
20. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999; 20: 307-12.
21. Johnson CM, Cooper AM, Frank AA, Orme IM. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 1998; 66: 1666-70.